Webjet Results Fly – Time to Buy
Webjet (WEB) released impressive first-half financial year results on Wednesday. Bookings, revenue and profit are all now above pre-market levels. Significant growth in the WebBeds segment and positive guidance
Webjet (WEB) released impressive first-half financial year results on Wednesday. Bookings, revenue and profit are all now above pre-market levels. Significant growth in the WebBeds segment and positive guidance
CBA released its Q1 trading update yesterday bringing the bank results season to a close. The market reacted well despite a slight fall in net interest margin. Business banking growth was the most impre
Telstra hosted its investor day yesterday. Not too much to report following their AGM last month. The share price had a (relatively) big fall of 2% as the company reported its fi
REA released its Q1 results on Friday which brokers liked but the market didn’t. The big news was the return of positive listings growth (only 1% but up from -18% in the previous Q) and a gain in market share over Domain. We like REA and while the housing market and NASDAQ goes up so should it. BUY
Macquarie has released first half-year earnings this morning which have fallen short of expectations. The results are not terrible but not great. We are hardly dazzled but won’t go against the market. Buying in the One Stock Portfolio with a watchful eye.
Endeavour Group (EDV) released its first Q trading update on Monday followed by the AGM yesterday. The key take-away was an overall Sales growth number of 2.1%, below consensus of 3.1% and a fairly positive short-medium term outlook.
Woolworths released first-quarter sales results on Wednesday and hosted its AGM yesterday. The results were mixed with Australian grocery sales outperforming while Big W and NZ underperformed.
JB HI-FI updated the market yesterday with its first-quarter sales and AGM. A similar story to Woolworths almost with JB Australia performing well, the Good Guys flat and JB NZ disappointing.
PLS has released September Quarter earnings this morning – Key points from the release are: Revenue has fallen 42% compared to Q2, coming in at $493m. 144kT of Spodumene Concentrate was produced (down 11% from prior Q). A similar amount was sold at a realised price of US$2240/T.